688276 百克生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.49513.2195.2049.37229.949
总资产报酬率 ROA (%)1.19510.7404.2937.33420.649
投入资产回报率 ROIC (%)1.47913.1645.1899.34228.219

边际利润分析
销售毛利率 (%)89.71890.23387.19388.29188.315
营业利润率 (%)23.77630.65117.44521.78833.452
息税前利润/营业总收入 (%)23.19030.22516.57420.83334.007
净利润/营业总收入 (%)22.40827.45716.94320.26229.017

收益指标分析
经营活动净收益/利润总额(%)92.902113.717128.993131.36696.178
价值变动净收益/利润总额(%)0.4160.1220.156-0.3911.319
营业外收支净额/利润总额(%)-0.2040.7925.452-0.1280.921

偿债能力分析
流动比率 (X)2.2632.2122.8722.9251.797
速动比率 (X)2.0302.0162.6032.6031.582
资产负债率 (%)19.86720.33016.90218.13527.865
带息债务/全部投入资本 (%)1.3780.2700.0760.062-0.091
股东权益/带息债务 (%)7,140.59036,887.943130,705.826161,096.588-109,108.093
股东权益/负债合计 (%)403.351391.895491.638451.433258.878
利息保障倍数 (X)-43.215-45.043-8.828-22.468139.477

营运能力分析
应收账款周转天数 (天)524.906249.781291.029224.188132.864
存货周转天数 (天)699.483395.045568.563495.593248.645